Real-time enrollment status for this nephropathic cystinosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:13 AM UTC
| NCT Number | NCT06910813 |
| Recruiting Status | Recruiting |
| Condition | Nephropathic Cystinosis |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of March 2, 2026: Clinical trial NCT06910813 is currently recruiting participants. This clinical trial study for nephropathic cystinosis is actively seeking new participants at 3 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06910813 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06910813 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.